Olstein Capital Management L.P. Purchases 13,000 Shares of UnitedHealth Group Inc (NYSE:UNH)

Olstein Capital Management L.P. boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 86.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 28,000 shares of the healthcare conglomerate’s stock after acquiring an additional 13,000 shares during the period. Olstein Capital Management L.P.’s holdings in UnitedHealth Group were worth $6,832,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in UNH. Canton Hathaway LLC purchased a new position in UnitedHealth Group during the 1st quarter valued at about $36,000. Truvestments Capital LLC purchased a new position in UnitedHealth Group during the 1st quarter valued at about $42,000. Coastal Capital Group Inc. purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $45,000. Creative Financial Designs Inc. ADV grew its holdings in UnitedHealth Group by 89.6% during the 1st quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after buying an additional 95 shares in the last quarter. Finally, Financial Gravity Wealth Inc. purchased a new position in UnitedHealth Group during the 1st quarter valued at about $58,000. Institutional investors and hedge funds own 85.87% of the company’s stock.

Shares of NYSE UNH traded down $4.50 during midday trading on Monday, hitting $244.13. 1,565,058 shares of the company’s stock were exchanged, compared to its average volume of 3,650,393. UnitedHealth Group Inc has a 12-month low of $208.07 and a 12-month high of $287.94. The company has a current ratio of 0.67, a quick ratio of 0.73 and a debt-to-equity ratio of 0.62. The stock has a market capitalization of $234.66 billion, a P/E ratio of 18.95, a price-to-earnings-growth ratio of 1.32 and a beta of 0.61. The firm has a fifty day moving average price of $251.66.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion during the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. UnitedHealth Group’s quarterly revenue was up 8.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.14 EPS. On average, equities research analysts forecast that UnitedHealth Group Inc will post 14.82 earnings per share for the current year.

In related news, Director William C. Ballard, Jr. sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the sale, the director now owns 61,309 shares in the company, valued at approximately $15,652,800.79. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the completion of the sale, the director now owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The disclosure for this sale can be found here. Insiders sold a total of 32,000 shares of company stock valued at $7,963,620 in the last 90 days. 0.87% of the stock is currently owned by corporate insiders.

A number of research analysts have weighed in on the company. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 target price for the company in a report on Monday, July 22nd. Barclays reduced their target price on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating for the company in a report on Wednesday, April 17th. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a report on Thursday, April 18th. Raymond James boosted their price objective on UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Oppenheimer set a $312.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $295.06.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What does earnings per share mean?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.